Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

A bibliometric analysis of the clinical development of drugs in Norway for the year 2000.

Hole OP, Winther FO, Cederkvist HR, Nitter-Hauge S.

Health Info Libr J. 2013 Jun;30(2):149-54. doi: 10.1111/j.1471-1842.2012.00981.x. Epub 2012 Mar 13.

2.

An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results.

Hole OP, Nitter-Hauge S, Cederkvist HR, Winther FO.

Eur J Clin Pharmacol. 2009 Mar;65(3):315-8. doi: 10.1007/s00228-008-0601-8. Epub 2008 Dec 23.

PMID:
19104790
3.

Twenty-five-year experience with the Medtronic-Hall valve prosthesis in the aortic position: a follow-up cohort study of 816 consecutive patients.

Svennevig JL, Abdelnoor M, Nitter-Hauge S.

Circulation. 2007 Oct 16;116(16):1795-800. Epub 2007 Sep 24.

PMID:
17893279
4.

An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.

Winther FO, Hole OP, Nitter-Hauge S.

Eur J Clin Pharmacol. 2007 Oct;63(10):909-12. Epub 2007 Aug 3.

PMID:
17673994
5.

Intraoperative angiography leads to graft revision in coronary artery bypass surgery.

Hol PK, Lingaas PS, Lundblad R, Rein KA, Vatne K, Smith HJ, Nitter-Hauge S, Fosse E.

Ann Thorac Surg. 2004 Aug;78(2):502-5; discussion 505. Review.

PMID:
15276506
6.

Coronary artery bypass grafting combined with aortic valve replacement in healthy octogenarians does not increase postoperative risk.

Brunvand H, Offstad J, Nitter-Hauge S, Svennevig JL.

Scand Cardiovasc J. 2002 Sep;36(5):297-301.

PMID:
12470398
7.

The importance of intraoperative angiographic findings for predicting long-term patency in coronary artery bypass operations.

Hol PK, Fosse E, Lundblad R, Nitter-Hauge S, Due-Tønnessen P, Vatne K, Smith HJ.

Ann Thorac Surg. 2002 Mar;73(3):813-8.

PMID:
11899185
8.

Graft control by transit time flow measurement and intraoperative angiography in coronary artery bypass surgery.

Hol PK, Fosse E, Mork BE, Lundblad R, Rein KA, Lingaas PS, Geiran O, Svennevig JL, Tonnessen TI, Nitter-Hauge S, Due-Tonnessen P, Vatne K, Smith HJ.

Heart Surg Forum. 2001;4(3):254-7; discussion 257-8.

PMID:
11673148
9.

[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin].

Gullestad L, Aass H, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Wikeby L, Nitter-Hauge S, Fjeld JG, Lien E, Ueland T, Frøland SS, Aukrust P.

Tidsskr Nor Laegeforen. 2001 Jun 20;121(16):1902-7. Norwegian.

10.

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.

Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P.

Circulation. 2001 Jan 16;103(2):220-5.

PMID:
11208680
11.

Duration of preoperative electrocardiographic QRS complex and the incidence of heart arrest after aorto coronary bypass surgery.

Abdelnoor M, Nitter-Hauge S, Risum O, Svennevig JL, Amlie JP.

Scand Cardiovasc J. 2000;34(2):186-91.

PMID:
10872708
12.

[Coronary surgery at the Heart Center in Oslo 1989-98].

Ovrum E, Tangen G, Oystese R, Dragsund S, Nitter-Hauge S.

Tidsskr Nor Laegeforen. 2000 Feb 28;120(6):658-61. Norwegian.

13.

Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.

Bjørnholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E.

Diabetes Care. 1999 Jan;22(1):45-9.

14.

[Mortality and morbidity after coronary bypass surgery in high-risk patients].

Risum O, Arafa O, Svennevig JL, Levorstad K, Abdelnoor M, Gullestad L, Bjørnerheim R, Simonsen S, Nitter-Hauge S.

Tidsskr Nor Laegeforen. 1998 Nov 30;118(29):4504-8. Norwegian.

PMID:
9889633
15.

[Mortality, recurrent angina pectoris and late myocardial infarction in patients surgically treated for coronary heart disease].

Risum O, Svennevig JL, Nitter-Hauge S, Levorstad K, Abdelnoor M.

Tidsskr Nor Laegeforen. 1998 Oct 20;118(25):3939-43. Norwegian.

PMID:
9830339
16.

The Denolin Lecture 1996. Mechanical heart valves. Conclusions from long-term follow-up.

Nitter-Hauge S.

Eur Heart J. 1997 Jun;18(6):907-10. Review. No abstract available.

PMID:
9183580
17.

Coronary artery bypass surgery in women and in men; early and long-term results. A study of the Norwegian population adjusted by age and sex.

Risum O, Abdelnoor M, Nitter-Hauge S, Levorstad K, Svennevig JL.

Eur J Cardiothorac Surg. 1997 Mar;11(3):539-46.

PMID:
9105821
18.

Fifteen-year experience with the medtronic-hall valve prosthesis. A follow-up study of 1104 consecutive patients.

Nitter-Hauge S, Abdelnoor M, Svennevig JL.

Circulation. 1996 Nov 1;94(9 Suppl):II105-8.

PMID:
8901728
19.

Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study.

Risum O, Nitter-Hauge S, Abdelnoor M, Levorstad K, Arafa O, Svennevig JL.

Eur Heart J. 1996 Jun;17(6):874-9.

PMID:
8781826
20.

[Cardiology education in Norway--does it keep up with the needs?].

Bjørnerheim R, Andreassen AK, Nitter-Hauge S, Smith P, Platou ES, Smiseth OA.

Tidsskr Nor Laegeforen. 1996 Mar 20;116(8):976-80. Norwegian.

PMID:
8650661
21.

Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery.

Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Gullestad L, Bjørnerheim R, Simonsen S, Nitter-Hauge S.

Scand J Thorac Cardiovasc Surg. 1996;30(2):71-5.

PMID:
8857678
22.

Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery bypass surgery.

Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Nitter-Hauge S.

Eur J Cardiothorac Surg. 1996;10(3):173-8.

PMID:
8664017
23.

Risk factors for early and late mortality in surgical treatment of coronary artery disease.

Risum O, Abdelnoor M, Svennevig JL, Nitter-Hauge S, Levorstad K, Foerster A, Frøysaker T.

Cardiovasc Surg. 1995 Oct;3(5):537-44.

PMID:
8574540
24.

Cardiac manifestations in mid-gut carcinoid disease.

Jacobsen MB, Nitter-Hauge S, Bryde PE, Hanssen LE.

Eur Heart J. 1995 Feb;16(2):263-8.

PMID:
7538079
25.

Increasing incidence of ventricular septal defects caused by improved detection rate.

Meberg A, Otterstad JE, Frøland G, Sørland S, Nitter-Hauge S.

Acta Paediatr. 1994 Jun;83(6):653-7.

PMID:
7919765
26.

Studies on the elimination of bilirubin pre-operatively in patients with mitral valve disease.

Bøhmer T, Kjekshus E, Nitter-Hauge S.

Eur Heart J. 1994 Jan;15(1):10-6.

PMID:
8174568
27.

[Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital].

Hjelmesaeth J, Rynning S, Halvorsen E, Otterstad JE, Vatne K, Nitter-Hauge S.

Tidsskr Nor Laegeforen. 1993 Nov 10;113(27):3342-5. Norwegian.

PMID:
8273057
28.

Does mitral stenosis need invasive investigation?

Nitter-Hauge S.

Eur Heart J. 1991 Jul;12 Suppl B:81-3. Review.

PMID:
1936032
29.

[Stiffness of the heart--stunning].

Thaulow E, Nitter-Hauge S.

Tidsskr Nor Laegeforen. 1991 Mar 20;111(8):938-41. Norwegian.

PMID:
2042208
30.

Long-term follow-up in isolated ventricular septal defect considered too small to warrant operation.

Otterstad JE, Erikssen J, Michelsen S, Nitter-Hauge S.

J Intern Med. 1990 Oct;228(4):305-9.

PMID:
2266337
31.

Spinal muscular atrophy type I combined with atrial septal defect in three sibs.

Møller P, Moe N, Saugstad OD, Skullerud K, Velken M, Berg K, Nitter-Hauge S, Børresen AL.

Clin Genet. 1990 Aug;38(2):81-3.

PMID:
2208769
32.

Relative survival of patients after heart valve replacement.

Abdelnoor M, Nitter-Hauge S, Trettli S.

Eur Heart J. 1990 Jan;11(1):23-8.

PMID:
2307161
33.

Antihypertensive therapy and blood lipids: alpha-blockers.

Thaulow E, Nitter-Hauge S.

Scand J Clin Lab Invest Suppl. 1990;199:45-8. Review. No abstract available.

PMID:
1972293
34.

Ten-year experience with the Medtronic Hall valvular prosthesis. A study of 1,104 patients.

Nitter-Hauge S, Abdelnoor M.

Circulation. 1989 Sep;80(3 Pt 1):I43-8.

PMID:
2766537
35.
37.

Morbidity in valvular heart replacement: risk factors of systemic emboli and thrombotic obstruction.

Abdelnoor M, Hall KV, Nitter-Hauge S, Rostad H, Risum O.

Int J Artif Organs. 1988 Jul;11(4):303-7.

PMID:
3410570
38.

May non-invasive methods replace catheterization in quantification of aortic stenosis?

Nitter-Hauge S, Ihlen H.

Eur Heart J. 1988 Apr;9 Suppl E:101-4. No abstract available.

PMID:
3042401
39.

Risk factors in surgically treated aortic and mitral valve disease.

Abdelnoor M, Hall KV, Nitter-Hauge S, Lindberg H, Ovrum E.

Scand J Thorac Cardiovasc Surg. 1988;22(1):29-33.

PMID:
3387947
40.

Risk factors in surgically treated mitral valve disease.

Abdelnoor M, Hall KV, Nitter-Hauge S, Lindberg H, Ovrum E.

Scand J Thorac Cardiovasc Surg. 1988;22(1):23-7.

PMID:
3387946
41.

Risk factors of morbidity and mortality in surgically treated chronic aortic valvular heart disease.

Abdelnoor M, Hall KV, Nitter-Hauge S, Golf S, Tretli S, Geiran O, Johansen A.

Rev Epidemiol Sante Publique. 1988;36(2):89-98. Review.

PMID:
3045922
43.

[Beta blockade in acute myocardial infarction].

Nitter-Hauge S.

Tidsskr Nor Laegeforen. 1987 Oct 10;107(28):2431-2. Norwegian. No abstract available.

PMID:
2891208
44.

Quantification of mitral regurgitation by Doppler echocardiography.

Zhang Y, Ihlen H, Myhre E, Levorstad K, Nitter-Hauge S.

Eur Heart J. 1987 Aug;8 Suppl C:59-62.

PMID:
3678248
45.

Intra-aortic balloon pumping support in surgically treated valvular heart disease: prognostic factors and survival.

Abdelnoor M, Hall KV, Golf S, Nitter-Hauge S, Ovrum E, Lindberg H.

Life Support Syst. 1987 Jul-Sep;5(3):233-9.

PMID:
3695583
46.

Management of multivalvular heart disease.

Nitter-Hauge S, Horstkotte D.

Eur Heart J. 1987 Jun;8(6):643-6.

PMID:
3622544
47.

[Combined coronary and peripheral arterial disease. Surgical treatment].

Rostad H, Nitter-Hauge S, Hennig R.

Tidsskr Nor Laegeforen. 1987 May 10;107(13):1115-7. Norwegian. No abstract available.

PMID:
3603467
48.

Analysis of methodology for quantifying mitral regurgitation by Doppler echocardiography.

Nitter-Hauge S, Ihlen H, Myhre E, Zhang Y.

Herz. 1986 Dec;11(6):327-31.

PMID:
3817724
49.

Estimation of the peak-to-peak pressure gradient in aortic stenosis by Doppler echocardiography.

Zhang Y, Ihlen H, Nitter-Hauge S.

Int J Cardiol. 1986 Mar;10(3):192-212.

PMID:
3957467
50.

Measurement of aortic regurgitation by Doppler echocardiography.

Zhang Y, Nitter-Hauge S, Ihlen H, Rootwelt K, Myhre E.

Br Heart J. 1986 Jan;55(1):32-8.

Supplemental Content

Loading ...
Support Center